argenx SE (NAS:ARGX)
$ 356.01 -3.47 (-0.97%) Market Cap: 21.22 Bil Enterprise Value: 18.74 Bil PE Ratio: 0 PB Ratio: 5.39 GF Score: 74/100

argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 10, 2021 / 08:15PM GMT
Release Date Price: $327 (-1.14%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Good afternoon, everybody, and good evening. Thanks for joining us for the last session of today. Very pleased to have argenx with us for this session.

Just quickly before I get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

And with that, I'm going to turn it over to Tim, who's going to make some opening comments, and then we'll jump right into Q&A.

Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director

Thank you, Matthew. Thank you very much for having us today. Greatly appreciated and a fantastic relationship between our firms.

What I would like to say, Matthew, is that argenx is in front of a very exciting period. We have been working really hard in the background, lining up a really exciting cadence of commercial launches for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot